Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database (09-SQOL)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01353677 |
Recruitment Status
:
Completed
First Posted
: May 16, 2011
Last Update Posted
: July 25, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hematopoietic Stem Cell Transplantation |
Study Type : | Observational |
Actual Enrollment : | 390 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Pilot Study to Assess the Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database |
Actual Study Start Date : | July 2011 |
Actual Primary Completion Date : | October 30, 2014 |
Actual Study Completion Date : | October 30, 2014 |
Group/Cohort |
---|
HSCT recipients
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years and older (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Adult (≥ 18 years), or pediatric (≥ 2 years and < 18 years) allogeneic HCT recipient (related, unrelated, or CBU) at participating pilot study transplant centers.
- Signed informed consent form from adult patient or parent/guardian of pediatric patient.
- Patient must have a valid mailing address within the United States to receive QOL surveys.
- Ability to speak and read English.
- Patients with access to a telephone.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01353677
United States, Florida | |
University of Florida | |
Gainesville, Florida, United States, 32610 | |
United States, Minnesota | |
Mayo Clinic | |
Rochester, Minnesota, United States, 55905 | |
United States, New York | |
Memorial Sloan-Kettering Cancer Center | |
New York, New York, United States, 10065 | |
United States, Ohio | |
Cincinnati Children's Hospital Medical Center | |
Cincinnati, Ohio, United States, 45229 | |
University Hospitals of Cleveland | |
Cleveland, Ohio, United States, 44106 | |
Cleveland Clinic | |
Cleveland, Ohio, United States, 44195 | |
United States, Washington | |
Fred Hutchinson Cancer Research Center | |
Seattle, Washington, United States, 98109 |
Principal Investigator: | Douglas Rizzo, MD, MS | CIBMTR/ Medical College of Wisconsin |
Responsible Party: | Center for International Blood and Marrow Transplant Research |
ClinicalTrials.gov Identifier: | NCT01353677 History of Changes |
Other Study ID Numbers: |
09-SQOL |
First Posted: | May 16, 2011 Key Record Dates |
Last Update Posted: | July 25, 2017 |
Last Verified: | July 2017 |
Keywords provided by Center for International Blood and Marrow Transplant Research:
Hematopoietic stem cell transplantation QOL |